The Bruton’s tyrosine kinase (BTK), a Tec family kinase, is considered a key regulator of (oncogenic) BCR signaling, critical for the pathogenesis and progression of CLL cells (122). The gene discussed is BCR; the disease is B-cell chronic lymphocytic leukemia.